Pharmacological Treatment of Ascites: Challenges and Controversies
Ascites is the most common complication from cirrhosis related to portal hypertension and depicts the onset of hepatic decompensation. Ranging from uncomplicated to refractory ascites, the progression carries prognostic value by reflecting the deterioration of underlying cirrhosis and portal hyperte...
Saved in:
| Main Authors: | Jimmy Che-To Lai, Junlong Dai, Lilian Yan Liang, Grace Lai-Hung Wong, Vincent Wai-Sun Wong, Terry Cheuk-Fung Yip |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-02-01
|
| Series: | Pharmaceuticals |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1424-8247/18/3/339 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ascites complications risk factors of decompensated cirrhosis patients: logistic regression and prediction model
by: Xiaolong Zheng, et al.
Published: (2025-05-01) -
Extracorporal modified ascitic fluid reinfusion in treatment of resistant ascites in liver cirrhosis
by: I. E. Onnintsev, et al.
Published: (2017-06-01) -
Real-world experience with long-term albumin in patients with cirrhosis and ascites
by: Enrico Pompili, et al.
Published: (2024-12-01) -
Nonselective beta-blockers in primary prophylaxis of esophageal variceal bleeding in patients with ascites waitlisted for liver transplantation
by: V. L. Korobka, et al.
Published: (2023-04-01) -
Guideline-Directed Medical Therapy in the Management of Cardiovascular Disease: A Cross-sectional Questionnaire-based Study amongst Indian Healthcare Professionals
by: Prafulla Kerkar, et al.
Published: (2025-04-01)